CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
35 research outputs found
The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
Author
The German and Austrian Xamoterol Study Group
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Effects of xamoterol on sodium excretion in volunteers.
Author
O'Connor
The German and Austrian Xamoterol Study Group
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The effects of age, sex and treatment with xamoterol on exercise capacity in patients with heart failure.
Author
Astrand
Blackwood
The German and Austrian Xamoterol Study Group
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
Author
Colucci
Furlong
The German and Austrian Xamoterol Study Group
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The effect of age and renal impairment on the pharmacokinetics of xamoterol.
Author
Bastain
Scott
The German and Austrian Xamoterol Study Group
Vigholt Sørensen
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
Author
Bilski
Binkley
+5 more
Currie
Lambertz
Nuttall
Rousseau
The German and Austrian Xamoterol Study Group
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients.
Author
Bastain
Marlow
+5 more
Nuttall
Snow
The German and Austrian Xamoterol Study Group
Waller
Weissler
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
Author
Brodde O-E
Brodde O-E
+3 more
Lefkowitz RJ
Paterson JW
The German and Austrian Xamoterol Study Group
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study
No full text
Crossref
The pharmacokinetics of xamoterol in liver disease.
Author
Bastain
Detry
+11 more
German and Austrian Xamoterol Study Group
Harry
Hashimoto
Jennings
Johnston
Marlow
Molajo
Nuttall
Rousseau
Sato
Scott
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol
Author
A. Charlesworth
A.J. Cowley
+12 more
Brown
Cowley
D.J. Van Veldhuisen
Dohmen HJM (on behalf of the PRIME-I Study Group)
F.X. Kleber
Hampton
J.R. Hampton
Packer
PROMISE Study Research Group
The Digitalis Investigation Group
The German and Austrian Xamoterol Study Group
The Xamoterol in Severe Heart Failure Study Group
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
1
2
3
4